EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H14ClFN4O |
| Net Charge | 0 |
| Average Mass | 356.788 |
| Monoisotopic Mass | 356.08402 |
| SMILES | COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(C)nnc1N2 |
| InChI | InChI=1S/C18H14ClFN4O/c1-9-16-18(24-23-9)21-14-8-15(25-2)13(20)7-11(14)17(22-16)10-5-3-4-6-12(10)19/h3-8H,1-2H3,(H2,21,23,24) |
| InChIKey | UOVCGJXDGOGOCZ-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| rg-1530 (CHEBI:750339) has role antineoplastic agent (CHEBI:35610) |
| rg-1530 (CHEBI:750339) is a benzodiazepine (CHEBI:22720) |
| Synonyms | Source |
|---|---|
| R-1530 | ChEMBL |
| RG-1530 | ChEMBL |
| Citations |
|---|